Akari Therapeutics Plc (AKTX)
7.52
-0.33
(-4.20%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Total Assets (Quarterly) : 38.62M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.62M |
| March 31, 2026 | 33.89M |
| December 31, 2025 | 48.00M |
| September 30, 2025 | 45.38M |
| June 30, 2025 | 50.91M |
| March 31, 2025 | 50.96M |
| December 31, 2024 | 50.66M |
| September 30, 2024 | 2.734M |
| June 30, 2024 | 5.076M |
| March 31, 2024 | 2.772M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 11.37M |
| March 31, 2022 | 19.45M |
| December 31, 2021 | 11.65M |
| September 30, 2021 | 14.72M |
| June 30, 2021 | 4.830M |
| March 31, 2021 | 7.840M |
| December 31, 2020 | 14.60M |
| September 30, 2020 | 13.69M |
| June 30, 2020 | 14.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.969M |
| December 31, 2019 | 6.802M |
| September 30, 2019 | 10.67M |
| June 30, 2019 | 5.151M |
| March 31, 2019 | 8.810M |
| December 31, 2018 | 8.030M |
| September 30, 2018 | 12.63M |
| June 30, 2018 | 17.12M |
| March 31, 2018 | 25.50M |
| December 31, 2017 | 29.05M |
| September 30, 2017 | 22.43M |
| June 30, 2017 | 32.05M |
| March 31, 2017 | 36.52M |
| December 31, 2016 | 46.36M |
| September 30, 2016 | 52.07M |
| June 30, 2016 | 57.63M |
| March 31, 2016 | 62.96M |
| December 31, 2015 | 69.89M |
| September 30, 2015 | 79.17M |
| June 30, 2015 | 2.96M |
| March 31, 2015 | 4.317M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 267.36M |
| argenx SE | -- |
| Autolus Therapeutics Plc | 493.23M |
| Evaxion AS | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.03M |
| Shareholders Equity (Quarterly) | 18.60M |
| Debt to Equity Ratio | 0.0373 |
| Current Ratio | 0.5973 |
| Net Debt Paydown Yield | 1.29% |